Rarity of AKT1 and AKT3 E17K mutations in squamous cell carcinoma of lung

Cell Cycle

Volumn 9, Issue 21, 2010, Pages 4411-4412

  Do, Hongdo ^a,b   Salemi, Renato ^b   Murone, Carmel ^c   Mitchell, Paul L ^c   Dobrovic, Alexander ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c AUSTIN HOSPITAL   (Australia)

Author keywords

AKT; E17K; High resolution melting; Lung cancer; Somatic mutation; Squamous cell carcinoma

Indexed keywords

AKT1 PROTEIN; AKT3 PROTEIN; E17K PROTEIN; PROTEIN; PROTEIN KINASE B INHIBITOR; UNCLASSIFIED DRUG;

ENZYME ACTIVATION; GENE MUTATION; HUMAN; LETTER; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SQUAMOUS CELL CARCINOMA;

EID: 78349233845     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.21.13654     Document Type: Letter

References (8)

1. Carpten JD, et al. Nature 2007; 448:439-44.
2. Altomare DA, et al. Oncogene 2005; 24:7455-64.
3. Davies MA, et al. Br J Cancer 2008; 99:1265-8.
4. Kim D, et al. J Biol Chem 2010; 285:8383-94.
5. Malanga D, et al. Cell Cycle 2007; 7.
6. Do H, et al. BMC Res Notes 2008; 1:14.
7. Bleeker FE, et al. Oncogene 2008.
8. Kim MS, et al. Br J Cancer 2008; 98:1533-5.